Ginkgo Bioworks (DNA)

• Market cap: $579M
• 1 day: 15.33%
• 5 days: 7.81%
• 1 month: 58.49%
• 3 months: 25.84%
• 6 months: -38.35%
• Year to date: -84.91%
• 1 year: -85.18%
• 5 years: -97.93%
• 10 years: -97.93%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

About: Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.

Employees: 1,218

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

62% more call options, than puts

Call options by funds: $9.01M | Put options by funds: $5.57M

6.17% more ownership

Funds ownership: 54.94% [Q2] → 61.1% (+6.17%) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]

32% less capital invested

Capital invested by funds: $313M [Q2] → $215M (-$99M) [Q3]

50% less funds holding

Funds holding: 313 [Q2] → 155 (-158) [Q3]

85% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 186

99% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 124